FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Biotech Venture Capital | Ambrx

Ambrx garners $10M in new funds

La Jolla, CA-based Ambrx has raised $10 million in new venture funds, adding to the $70 million it has already raised from the likes of 5AM Ventures and Aravis and Versant. Ambrx has been developing a novel protein modification platform. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Biotech Venture Capital   Ambrx  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.